John Lunger

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Adaptimmune Therapeutics PLC (ADAPY)
Proxy statement

Current
Adaptimmune Therapeutics PLC (ADAPY)
Proxy statement

Start not stated–2025-08-31

Recorded roles and earnings-call appearances connecting this person to public companies.

ADAPY

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2021	Adaptimmune Therapeutics PLC (ADAPY)	Chief Operating Officer	$430,000	—	—	$1,069,101	$183,825	$32,083	$1,715,009
2020	Adaptimmune Therapeutics PLC (ADAPY)	Chief Operating Officer	$400,000	—	—	$857,661	$198,000	$31,802	$1,487,463
2019	Adaptimmune Therapeutics PLC (ADAPY)	Chief Operating Officer	$366,867	—	—	$435,546	$94,542	$35,655	$932,610

No earnings-call appearances or filed executive changes recorded yet.